New York Assembly Bill A09156

New York 2025-2026 Regular Session

• Introduced: 10/17/25
• Refer: 10/17/25
• Refer: 1/7/26
• Report Pass: 5/11/26
• Refer: 5/11/26
• Report Pass: 5/28/26
• Refer: 5/28/26

Caption

Prohibits the sale of products that contain 7-hydroxymitragynine at a level that exceeds 2% of total alkaloids or one milligram per serving; establishes fines for the sale of such products.

Impact

If enacted, A09156 would amend the general business law to clearly delineate the legal boundaries concerning the sale of 7-hydroxymitragynine products. It would prohibit any corporation or business entity from knowingly selling or distributing these products within the state. Violations of this regulation would lead to civil penalties, which start at a fine of up to three thousand dollars for a first offense, increasing to six thousand five hundred dollars for subsequent violations. This framework seeks to discourage illegal sales and ensure a safer marketplace for consumers in New York.

Summary

A09156 is a proposed legislative measure in New York aimed at prohibiting the sale of 7-hydroxymitragynine products, which are defined as substances that contain this specific compound at a concentration exceeding two percent of total alkaloids or one milligram per serving. This bill is introduced as a response to growing concerns regarding the safety and health implications of such products, which are often associated with the herbal supplement kratom. The intent is to safeguard consumers from potentially harmful substances that have not been adequately studied for their effects and safety in the market.

Contention

While the bill primarily focuses on consumer safety, it may face opposition from proponents of herbal remedies and alternative health products. Critics may argue that such a sweeping ban could undermine consumer choice and that existing regulations should instead be focused on proper labeling and consumer education rather than outright prohibition. This division may stem from varying views on the efficacy and safety of herbal products, with advocates emphasizing the need for regulation that preserves access to these alternatives while ensuring public safety.